Market Tracker

08/29 5:16pm ET

Incyte Corp (NASDAQ:INCY)

81.33
Delayed Data
As of 3:59pm ET
 +0.29 / +0.36%
Today’s Change
55.00
Today|||52-Week Range
133.62
-25.01%
Year-to-Date

Today’s Trading

Previous close81.04
Today’s open81.10
Day’s range80.09 - 81.88
Volume591,455
Average volume (3 months)1,139,869
Market cap$15.2B
Dividend yield--
Data as of 3:59pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+476.82%
Earnings growth (next 5 years)+118.55%
Revenue growth (last year)+47.36%
P/E ratio214.0
Price/Sales26.95
Price/Book88.38

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.48-0.50%
MDVNMedivation Inc-0.07-0.09%
PRGOPerrigo Company PLC+0.43+0.49%
VRXValeant Pharmaceutic...-0.58-1.88%
Data as of 4:01pm ET, 08/29/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts